• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail
-

FDA-TRACK Archive

The list below provides information on FDA's performance measures and projects as aligned to FDA strategic priorities and program offices. This list enables you to view charts of performance data and progress on important projects and programs.

To view current FDA-TRACK performance measures and projects view the Active Index

Filter







Results

Number of results:25

ItemProgramOfficeFY CompletedStrategic PlanStrategic Goal/Area
1 Number of inspections completed by investigators and detailees based in-country during the month OIP Office of International Programs N/A N/A
2 Number of high priority inspections completed by investigators and detailees based in-country during the month OIP Office of International Programs 2014 N/A N/A
3 Number of routine inspections completed by investigators and detailees based in-country during the month OIP Office of International Programs 2014 N/A N/A
4 Average number of days to complete an inspection in the month OIP Office of International Programs 2013 N/A N/A
5 Number of investigators and detailees available to conduct inspections in the quarter OIP Office of International Programs 2013 N/A N/A
6 Number of verifications of foreign firm registrations completed in the month OIP Office of International Programs 2013 N/A N/A
7 Number of workshops/conferences for regulatory authorities and industry held in foreign countries in which OIP participates during the month OIP Office of International Programs 2012 N/A N/A
8 Number of workshops/conferences for regulatory authorities and industry held in the U.S. in which OIP staff participates during the month OIP Office of International Programs 2012 N/A N/A
9 Number of inspections completed by investigators based in-country in the month OIP Office of International Programs 2012 N/A N/A
10 Number of investigations completed by investigators based in-country in the month OIP Office of International Programs 2012 N/A N/A
11 Number of verifications of foreign firm registrations completed in the month OIP Office of International Programs 2012 N/A N/A
12 Train-the-trainer Good Clinical Practices (GCP) OIP Office of International Programs - Africa Office 2011 N/A N/A
13 Informatics Pilot OIP Office of International Programs - Asia-Pacific Office 2012 N/A N/A
14 AQSIQ Regulatory Assessment OIP Office of International Programs - China Office 2011 N/A N/A
15 Training on Good Clinical Practices OIP Office of International Programs - China Office 2012 N/A N/A
16 FDA-EMA Tracking Database OIP Office of International Programs - Europe Office 2012 N/A N/A
17 Regulatory Oversight Bodies OIP Office of International Programs - India Office 2011 N/A N/A
18 Pursue Agreement with Indian Counterparts to Facilitate Communication and Collaboration OIP Office of International Programs - India Office 2012 N/A N/A
19 Over-the-Counter (OTC) Good Manufacturing Practices (GMP) Pilot OIP Office of International Programs - India Office 2012 N/A N/A
20 Database for Latin America Region OIP Office of International Programs - Latin America Office 2011 N/A N/A
21 Library of Spanish Presentations on Key Frequently Requested FDA Topics OIP Office of International Programs - Latin America Office 2012 N/A N/A
22 Pilot Program: Sharing “Health Hazard” Class 3 Sample Laboratory Results (HC3SLR) with Foreign Government Competent Authorities (FGCA) OIP Office of International Programs - Latin America Office 2012 N/A N/A
23 Food Safety Conference in the Middle East (Cairo) OIP Office of International Programs - Middle East and North Africa Office 2011 N/A N/A
24 Middle East and North Africa Region Science-based Food Safety System Course OIP Office of International Programs - Middle East and North Africa Office 2012 N/A N/A
25 Non-Public Information Sharing Program OIP Office of International Programs - Office of Global Engagement 2012 N/A N/A

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information in the Archive Index may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.


-
-